Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arginine in classic galactosemia
NCT03580122Phase 2Completed
- Sponsor
- Maastricht University Medical Center+
- Start
- Dec 2017
- Primary completion
- Jan 2018
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of arginine aspartate in classic galactosemia, sponsored by Maastricht University Medical Center+. Started Dec 2017; status: completed.
02
Drugs
arginine aspartate
03
Conditions
classic galactosemia
Beyond the preview
Go deeper on NCT03580122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03580122.